Navigation Links
Abattis Biologix Corporation Begins Trading on Pink Sheets
Date:6/17/2011

VANCOUVER, British Columbia, June 17, 2011 /PRNewswire/ -- Abattis Biologix Corporation (CNSX: FLU) announced today that their shares have commenced trading on the OTC Pink Sheets under the symbol ABBTF. Pink Sheet trading will provide shareholders with liquidity as the company proceeds with financing activities and the preparation of additional disclosure documents for listing on higher tier OTC platforms and other exchanges.

Mike Withrow, CEO of Abattis stated, "This is the first in three steps toward becoming a fully reporting issuer with the SEC. The company is fully reporting in Canada and is in the process of converting to IFRS. It will provide transparency about our company in both countries and better access to its stock in the US, which will attract new investors and expand our stockholder base."

"We continue to strengthen our IP and are preparing to launch our portfolio of proprietary products into strategic distribution channels. Shareholders and investors should expect to see additional news releases in the coming weeks on these and other events and activities as we move toward that goal," added Withrow.

About Abattis Biologix Corp.

Abattis Biologix Corporation is committed to the research, development and marketing of proprietary natural health and wellness solutions that address chronic illnesses through targeted nutritional support.  We manufacture and market the most scientifically advanced natural therapeutic formulas based on proprietary technologies through multiple distribution channels, while providing the highest level of customer service.

Web: www.abattis.com     Twitter:@abattis

Safe Harbor Statement: This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21 E of the Securities Exchange Act of 1934, as amended. Investors are cautioned that these forward-looking statements involve uncertainties and risk that could cause actual performance and results of operations to differ materially from those anticipated.

Media Contact:
Margie Adelman
madelman@adelmanpr.com
916 220 3500

Investor Relations Contact:
Gil Schneider
Gil.schneider@abattis.com
604 828 8600


'/>"/>
SOURCE Abattis Biologix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Volcano Corporation Presentation at Wells Fargo Conference to be Webcast
2. Theramed Corporation to Launch Glenveigh Products, ebb™ and jetty™ at the Society of Obstetricians and Gynecologists of Canada
3. Mitsubishi Chemical Medience Corporation Receives 510(k) Clearance for PATHFAST® cTnI-II (cardiac Troponin I) Test in U.S.
4. Spectros Corporation Introduces Continuum®, a Broadband Infrared Sensor for Brain and Gut Oximetry
5. AmbiCom Forms Joint Alliance With E-Care Technology Corporation
6. Volcano Corporation Presentation at William Blair Conference to be Webcast
7. President of Minntech Corporation Injured in Plane Crash
8. Translational Sciences Corporation to Launch OncoTrac™ at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
10. Volcano Corporation Presentation at Goldman Sachs Conference to be Webcast
11. EMIT Corporation Receives FDA 510(k) Clearance for HypothermX™ Blood and Fluid Warmer.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... 2017 Research and Markets has announced ... Opportunities, and Future" report to their offering. ... This research service on the ... technologies, and provides a snapshot of the key participants in the ... are provided from 2016 to 2020. The market is expected to ...
(Date:1/20/2017)... -- Avillion LLP, a co-developer and financier of late-stage ... MD MBA as Chief Medical Officer. Dr Weinberg will be based ... ... spent more than 17 years as a pharmaceutical and biotech executive ... Over the course of his career, he has interfaced with the ...
(Date:1/19/2017)... , Jan. 19, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
Breaking Medicine Technology:
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well has launched two ... drinks have been produced in collaboration with Zlatan Ibrahimovic and have been developed ... After a successful launch in Sweden last year, the next generation sports drinks ...
(Date:1/20/2017)... ... ... Angel”: a heartwarming and earnest tale of faith and believing in the path ... the creation of published author, Marjorie Lund-Fontaine, a former professional violinist, alumnus of The ... of her new book, Marjorie says, “‘The Angel’ was written as a fairytale, but ...
(Date:1/20/2017)... ... 2017 , ... “I Forgive You”: a fine examination of how God handles sin, including ... of published author, Stephen Miller, who, for over ten long years has been waiting to ... in Trinidad and Tobago, he has been serving the Lord for over twenty years, and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... “Christmas in ... creation of published author, Sara Seymour, who lives in Lafayette, Indiana where she works ... sips on iced coffees and writes. , Published by Christian Faith Publishing, Sara Seymour’s ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Knowledge is God’s Lighthouse”: a moving and ... God’s Lighthouse” is the creation of published author, Gene Gaapf, a retired truck driver, ... , “I have been writing since high school and have many different titles,” Gaapf ...
Breaking Medicine News(10 mins):